Array BioPharma, Inc. (ARRY) to Present at the Piper Jaffray Annual Healthcare Conference  
11/15/2012 10:42:50 AM

BOULDER, Colo., Nov. 15, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare Conference in New York City.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.  



Piper Jaffray Annual Health Care Conference


Ron Squarer, Chief Executive Officer


Tuesday, November 27, 2012


11:30 a.m. Eastern Time


The New York Palace, NY


About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted smallmolecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two whollyowned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.  For more information on Array, please go to


Tricia Haugeto

Array BioPharma Inc.


SOURCE Array BioPharma Inc.